AOAAM Addiction Medicine Board Certification Review Course

  • 11/7 Addiction Medicine Board Certification Review Course - Review Q&A Session

    Contains 1 Component(s) Includes a Live Web Event on 11/07/2020 at 10:00 AM (EST)

    Addiction Medicine Board Certification Review Course - Review Q&A Session

    Q&A Session with all speakers from the Addiction Medicine Board Certification Review Course 

  • Challenges in Pain and Addiction

    Contains 2 Component(s), Includes Credits

    Acute and chronic pain treatment has been associated with the opioid epidemic. Compassionate and competent pain treatment can be provided with reductions in risk of opioid complications. Osteopathic evaluation and treatment will be included.

  • Introduction and Welcome / A Genetic and Neurobiologic Understanding of Addiction

    Contains 2 Component(s), Includes Credits

    In this course there will be a review of the genetic underpinnings of the individual susceptibility and development of addiction. This will be tied into the potential environmental and epigenetic influences on genetics. Flowing from there will be a review of the current understanding of the neurobiology of addiction, from first reward to the development of the disease.‚Äč

  • A Comprehensive Review of Opioid Use Disorder

    Contains 2 Component(s), Includes Credits

    This course reviews the epidemiology of opioid use disorder and opioid overdose deaths, diagnosis of opioid use disorder, opioid intoxication, and opioid withdrawal, in addition to treatments for opioid withdrawal, and medications for opioid use disorder.

  • Tobacco Use Disorders

    Contains 2 Component(s), Includes Credits

    This presentation will review the diagnoses, epidemiology, and management of Tobacco Use Disorders to include smokeless tobacco, E-Cigarettes, co-occurring disorders, and medication assisted options.

    This presentation will review the diagnoses, epidemiology, and management of Tobacco Use Disorders to include smokeless tobacco, E-Cigarettes, co-occurring disorders, and medication assisted options. 

    11:00am-11:50am
    Tobacco Use Disorders

    R. Gregory Lande, DO, FAOAAM

    R. Gregory Lande, DO, FAOAAM

    R. Gregory Lande, DO is a past president of the AOAAM.

    Dr. Lande retired from active duty military service and now practices psychiatry at Walter Reed National Military
    Medical center in Bethesda, MD.
    He is the author of over 100 articles, chapters, and books.

  • Saturday Lunch Time Q&A

    Contains 2 Component(s), Includes Credits

    Question and Answer Session with today's speakers

  • Cannabis / Medical Marijuana

    Contains 2 Component(s), Includes Credits

    This session reviews the epidemiology of cannabis use disorder, diagnosis of cannabis use disorder, cannabis intoxication, and cannabis withdrawal. Medical marijuana policies and legalization of cannabis will be reviewed.

    This session reviews the epidemiology of cannabis use disorder, diagnosis of cannabis use disorder, cannabis intoxication, and cannabis withdrawal. Medical marijuana policies and legalization of cannabis will be reviewed.

    12:30pm-1:20pm

    Cannabis / Medical Marijuana

    Marla Kushner, DO, FAOAAM

    Marla Kushner, DO, FAOAAM

    Doctor Marla Kushner graduated from the Michigan State University College of Osteopathic Medicine. She completed her family medicine residency at Botsford General Hospital in Farmington Hills, MI and completed an Adolescent Young Adult Medicine Fellowship at Chicago Osteopathic Hospital of Rush Presbyterian St. Luke's Hospital in Chicago. After her fellowship, Dr. Kushner began working with adolescent substance abuse facilities in Chicago and received certification and Addiction Medicine from the American Society of Addiction Medicine and is a distinguished fellow of ASAM. She is a diplomate in American Board of Addiction Medicine. Dr. Kushner received her fellowship in the American College of Osteopathic Family Physicians in March 2013 and is currently medical director of the Addiction Recovery Track at Insight Behavioral Health in Chicago and  two high school-based health centers in Chicago. She has a family medicine practice with a focus on adolescent an addiction medicine. 

  • A Comprehensive Review of Alcohol Use Disorders

    Contains 2 Component(s), Includes Credits

    During this course there will be a review of the epidemiology of alcohol use disorders. There will information on the individual susceptibility to the disease and how understanding this can lead to individualize prevention. The screening for and brief intervention of alcohol use, will be reviewed along with the biologic markers of the disease. Treatment of alcohol use disorders will be reviewed from current withdrawal recommendations to post abstinent chronic care.

  • Stimulant Use Disorder: Clinical & Practice Implications

    Contains 2 Component(s), Includes Credits

    Stimulant use disorder includes amphetamines, methamphetamines, cocaine, and other stimulants. This presentation covers the neurobiology of stimulant use disorder, definition of stimulant use disorder and prevalence, its clinical manifestations including intoxication and withdrawal, misuse and diversion of prescription stimulants, and treatment approaches for individuals with stimulant use disorder.

    Stimulant use disorder includes amphetamines, methamphetamines, cocaine, and other stimulants. This presentation covers the neurobiology of stimulant use disorder, definition of stimulant use disorder and prevalence, its clinical manifestations including intoxication and withdrawal, misuse and diversion of prescription stimulants, and treatment approaches for individuals with stimulant use disorder. 

    Stimulant Use Disorder: Clinical & Practice Implications

    3:30pm-4:20pm

    Antoine Douaihy, MD

    Antoine Douaihy, MD

    Professor of Psychiatry & Medicine, University of Pittsburgh School of Medicine

    Dr. Douaihy is a Professor of Psychiatry and Medicine, Senior Academic Director of Addiction Medicine Services (AMS) and Addiction Psychiatry Fellowship at Western Psychiatric Hospital of the University of Pittsburgh Medical Center (UPMC), and Co-Director of the Tobacco Treatment Service of UPMC. His areas of clinical and research expertise and interest are substance use disorders (SUDs) and SUDs co-occurring with psychiatric disorders in adults and adolescents, psychiatric disorders in individuals with HIV/HCV, smoking cessation and psychosocial approaches, particularly motivational interviewing, and medication trials for co-occurring disorders, opioid and stimulant use disorders. He has a demonstrated record of expertise and experience in SUDs and a well established record of leadership and expertise in conducting multi-site clinical trials. He has served as Principal Investigator (PI), Co-I, or a consultant on studies funded by NIAAA, NIDA, NIMH, SAMHSA, and pharmaceutical industries. He served as a member of the Opioid Addiction Task Force (established in the U.S. District Attorney in Allegheny County) and the opioid addiction and recovery task force at the University of Pittsburgh. He is currently the vice chair of Pittsburgh HIV/AIDS Commission and a member of the physician work group on medical marijuana at the PA Department of Health.

  • Q&A Session

    Contains 2 Component(s), Includes Credits

    Question and Answer Session with today's speakers